← Back to All Filings

Edwards Lifesciences CVP Sells ~$954k in EW Stock

Low SignificanceDecember 12, 2025 at 6:02:31 PM EST

Edwards Lifesciences Corp

$EW4CIK: 0001099800

Subscribe to track EW

Premium users can add ticker alerts and receive realtime notification updates.

Filing Summary

Edwards Lifesciences CVP Sells ~$954k in EW Stock

Company: Edwards Lifesciences Corp (EW) Form: 4 | Filed: 2025-12-12 Significance: Low

Insider: BOBO DONALD E JR Title: CVP,Strategy/Corp Development | Relationship: Officer

Transaction (Sale): • Type: Sell • Shares: 11,386 • Price: ~$83.77 (avg) • Value: $953,735 • Owned After (Direct): 31,870

Key Insight: An insider sold shares valued at under $1 million, representing a negligible 0.0019% of the company's $50.08B market cap. The filing also notes a gift of 7,100 shares.

Market Context: This transaction is considered routine and immaterial given the company's large-cap status. The sale represents a small fraction of the company's total shares outstanding.

Comprehensive Analysis

SEC Filing Analysis: Edwards Lifesciences Corp (EW)

Executive Summary

  • Trading Significance: Low
  • Key Takeaway: A Corporate Vice President at Edwards Lifesciences executed a sale of common stock totaling approximately $954,000. The transaction's size is immaterial relative to the company's $50.08 billion market capitalization.
  • Market Impact: The transaction is too small to have a meaningful impact on the stock's price or trading volume.

Company Information

FieldValue
CompanyEdwards Lifesciences Corp
Ticker SymbolEW
CIK0001099800
IndustryOrthopedic, Prosthetic & Surgical Appliances & Supplies

Insider Information

FieldValue
NameBOBO DONALD E JR
CIK0001196661
Title/PositionCVP,Strategy/Corp Development
RelationshipOfficer

Transaction Details

This filing reported multiple transactions. The primary transaction analyzed is the aggregate open market sale.

FieldValue
Form Type4
Transaction Date2025-12-12
Transaction CodeS (Sale)
Security TypeCommon Stock
Shares Involved11,386.1175
Price Per Share~$83.77 (Weighted Avg.)
Total Value$953,735.19
Shares Owned After31,870.2532 (Directly)
Ownership TypeDirect

Financial Impact Assessment

Transaction Materiality

MetricValue
Transaction Value$953,735.19
% of Market Cap0.0019%
Shares Transacted11,386.1175
% of Shares Outstanding0.0019%
Post-Transaction Ownership205,840 shares (0.035% of outstanding, including indirect holdings)
Materiality AssessmentLow

Impact Evaluation

  • Market Cap Context: For a large-cap company with a market capitalization of $50.08 billion, a transaction of less than $1 million is considered routine and financially insignificant.
  • Ownership Concentration: The insider's total holdings, both direct and indirect, constitute a very small fraction (0.035%) of the total shares outstanding, indicating low ownership concentration.
  • Transaction Significance: The sale represents less than 0.002% of both market cap and shares outstanding, placing it well below any threshold for market significance. It is likely related to personal financial management, such as tax planning or diversification.

Market Impact Analysis

Stock Impact Prediction

  • Direction: Neutral
  • Reasoning: The transaction is immaterial in both absolute dollar value and relative to the company's size. It does not signal any meaningful change in the insider's conviction or outlook.

Volume & Sentiment

  • Expected Volume Impact: Negligible. The number of shares sold is a tiny fraction of the typical daily trading volume for EW.
  • Sentiment Indicator: Neutral. This type of small, routine sale by an executive is common and does not typically influence market sentiment.

Additional Context

Transaction Notes

  • Other Transactions: The filing also disclosed a disposition of 7,100 shares as a gift (Transaction Code 'G'), which is a non-market transaction and carries no direct market signal.
Topics:#SECFiling#InsiderTrading#Form4#EW#EdwardsLifesciences#InsiderSell#StockMarket#Investing#MarketAnalysis

Get Real-Time Alerts

Join our community to receive instant notifications when high-significance filings are published

Important Disclaimer

This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.

Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.